APOL1 genotyping could be helpful and clinical testing is recommended in different clinical conditions, such as kidney transplant patients, living donors, HIV-infected patients, FSGS, lupus nephritis, and interferon treatment candidates (Kruzel-Davila et al., 2017; Kopp and Winkler, 2020). Here, APOL1 is linked to lupus nephritis.